A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2006
11/07/2006	US7132436 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
11/07/2006	US7132434 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders
11/07/2006	US7132430 Treatment of cardiovascular and related pathologies
11/07/2006	US7132429 Sulfonamido ether substituted imidazoquinolines
11/07/2006	US7132416 Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia
11/07/2006	US7132408 Composition and method for inhibiting platelet aggregation
11/07/2006	US7132397 Bone morphogenetic protein antagonist based on the mature protein
11/07/2006	US7132392 administering to mammals peptides having angiostatic activity, that inhibit hepatocyte growth factor induced cell migration and binding between intracellular transducers and receptor protein tyrosine kinases; anticarcinogenic agents
11/07/2006	US7132264 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
11/07/2006	US7132255 drug screening for compounds that enhance or suppress killer T cell activity by contacting a population of killer T cells which express biliary glycoprotein with a compound that binds biliary glycoprotein and determining the cytotoxicity or proliferation of the killer T cells relative to a control
11/07/2006	CA2416879C Methods of treating cancer and the pain associated therewith using endothelin antagonists
11/07/2006	CA2375093C Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
11/07/2006	CA2281755C Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/07/2006	CA2261988C Mannose-6-phosphate composition and its use in treating fibrotic disorders
11/07/2006	CA2260943C Formulation of 5-ht agonists
11/07/2006	CA2158268C N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
11/02/2006	WO2006115436A1 Medicinal agent for preventing progression of apoptotic and jugulating necrotic changes in the organism tissues
11/02/2006	WO2006115285A1 Pharmaceutical composition
11/02/2006	WO2006115279A1 Composition for preservation of vascular endothelium
11/02/2006	WO2006115274A1 Myeloerythroid progenitor differentiation inducer
11/02/2006	WO2006115247A1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR
11/02/2006	WO2006115245A1 4-ethynylisoquinoline derivative and pharmaceutical preparation comprising the same
11/02/2006	WO2006115244A1 4-bromoisoquinoline derivative and pharmaceutical preparation comprising the same
11/02/2006	WO2006115221A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	WO2006115193A1 Remedy for xanthoma
11/02/2006	WO2006115170A1 Hsv1-hf10 virus therapy for head-and-neck cancer
11/02/2006	WO2006115154A1 Crystal polymorphism of 4’-{2-[(1s,2r)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethylamino]ethoxy}-3-isopropyl-3’,5’-dimethylbiphenylcarboxylic acid hydrochloride
11/02/2006	WO2006115137A1 2-aminobenzimidazole derivative and use of the same for medical purposes
11/02/2006	WO2006115026A1 Humanin receptor or humanin-like polypeptide receptor
11/02/2006	WO2006114703A2 Method of administration of (1s,s2) -1- (4 -hydroxyphenyl) -2- (4-hydr0xy-4-phenylpiperidin-1-yl) -1- propano (traxoprodil)
11/02/2006	WO2006072809A3 Formulations that optimize intracellular concentration of nicotinamide adenine (nad+) and methods of use to protect cells and treat diseases and conditions
11/02/2006	US20060248605 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2006	US20060248601 Modification of organelle metabolism by unc-51-like kinases roma1 or 2tm proteins
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247313 administering to a osteoporosis patient an effective amount of a amino acid formulation containing 10 to 40 parts by weight of L-arginine or L-glutamine; 5 to 20 parts of L-valine; 8 to 30 parts of L-isoleucine; and10 to 35 parts of L-leucine; regeneration of tendon and ligamet; antiaging of skin
11/02/2006	US20060247310 Body temperature elevating agents
11/02/2006	US20060247302 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
11/02/2006	US20060247299 administering HMG-CoA reductase inhibitor; for treatment of diabetes and complications caused by insulin resistance syndrome
11/02/2006	US20060247280 Non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis; 3-Benzyl-5-(benzylthio)-1,2,4-triazole
11/02/2006	US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247240 Method of treatment and/or prevention of brain, spinal or nerve injury
11/02/2006	US20060247223 Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
11/02/2006	US20060247212 Heterocyclic compounds having inhibitory activity against HIV integrase
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	US20060247198 TGF-beta type receptor cDNAs encoded products and uses therefor
11/02/2006	US20060247186 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
11/02/2006	US20060247179 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
11/02/2006	US20060247176 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
11/02/2006	US20060247162 Skin collagen production promoter
11/02/2006	US20060246433 Method and nucleic acids for the analysis of a colon cell proliferative disorder
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	US20060246101 Oral controlled release formulations
11/02/2006	US20060246077 Use of antibodies against the MUC18 antigen
11/02/2006	US20060246069 Inflammation and immunopathy caused by human anti-human Monocyte chemoattractant protein-1
11/02/2006	US20060246062 Anti-ccr4 antibodies and methods of use therefor
11/02/2006	US20060246046 Modified tridegins, production and use thereof as transglutaminase inihibitors
11/02/2006	US20060246012 Delivery of physiologically active compounds through an inhalation route
11/02/2006	US20060246011 Delivery of diphenhydramine through an inhalation route
11/02/2006	EP1717310A1 Lineage-directed induction of human mesenchymal stem cell differentiation
11/02/2006	EP1717251A2 Methods of therapy for B-cell malignancies using human anti-CD40 antibodies
11/02/2006	EP1717244A1 Akt activity specifically inhibiting polypeptide
11/02/2006	EP1717230A1 Fused-ring 4-oxopyrimidine derivative
11/02/2006	EP1717229A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1717224A1 Peptidyl arginine deiminase type iv inhibitor
11/02/2006	EP1716867A1 Preventives for migraine
11/02/2006	EP1716864A1 Neural regeneration using home bone morphogenetic proteins
11/02/2006	EP1716861A2 Inhibitors of proteasomal activity for stimulating bone and hair growth
11/02/2006	EP1716857A1 Composition for nkt cell activation
11/02/2006	EP1716856A2 The treatment of acne
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1715857A1 Amidine derivatives for treating amyloidosis
11/02/2006	EP1517682B1 Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant
11/02/2006	EP1448195B1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
11/02/2006	EP1446394B1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
11/02/2006	EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006	EP1406620B1 Vinyl phenyl derivatives as glk activators
11/02/2006	EP1395568B1 4-aminopyrimidine derivatives
11/02/2006	EP1387689B1 Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof
11/02/2006	EP1343773B1 Thiazole derivatives for traeing ppar related disorders
11/02/2006	EP1339685B1 Biphenylcarboxamides useful as lipid lowering agents
11/02/2006	EP1250313B1 Monohydrate of cis-lithium-cyano-4- 3-(cyclopentyloxy)-4-methoxyphenyl\|cyclohexanecarboxylate
11/02/2006	EP1244446B1 Thrombopoietin mimetics
11/02/2006	EP1223925B1 Fatty acid derivative for the treatment of external secretion disorders
11/02/2006	EP1214295B1 Hydroxyacetamidobenzenesulphonamide derivatives
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1180035B1 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1-alpha, 25-DIHYDROXY VITAMIN D3
11/02/2006	EP1036063B1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0854722B1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods
11/02/2006	EP0823908B1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
11/02/2006	EP0821683B1 Benzimidazole compounds and their use as modulators of the gaba a receptor complex
11/02/2006	EP0769961B1 Use of bacterial enzymes e.g. heparinases, chondroitinases for modulating wound healing processes
11/02/2006	CA2605383A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	CA2605381A1 Crystal polymorphism of 4'-{2-[(1s,2r)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethylamino]ethoxy}-3-isopropyl-3',5'-dimethylbiphenylcarboxylic acid hydrochloride
11/02/2006	CA2605365A1 Remedy for xanthoma
11/01/2006	CN1856504A Anti-infarction molecules

1 ... 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 ... 1564